COVID-19 patients in light of shortages.The group of scientists advising Ontario on the pandemic published revised clinical guidelines this week reflecting the shortage of tocilizumab.
Ontario issuing stay-at-home order, declares 3rd state of emergency amid COVID-19 pandemic The COVID-19 science advisory table says the drug is recommended for critically and moderately ill COVID-19 patients within 14 days of hospital admission.This week the group’s guidance was updated to recommend a fixed dose of 400 milligrams per patient and no second dose.
COVID-19 in Toronto neighbourhoods: How postal code data highlights vaccine inequities Dr. Peter Juni of the science table says the change is unlikely to impact patients’ treatment but it was.